Cargando…
Impact of the COVID-19 Pandemic on Inpatient Antibiotic Consumption in Switzerland
The aim of this study was to analyze inpatient antibiotic consumption during the first 16 months of the COVID-19 pandemic in Switzerland. The entire period (January 2018–June 2021) was divided into the prepandemic period, the first and second waves, and the intermediate period. In the first year of...
Autores principales: | Friedli, Olivier, Gasser, Michael, Cusini, Alexia, Fulchini, Rosamaria, Vuichard-Gysin, Danielle, Halder Tobler, Roswitha, Wassilew, Nasstasja, Plüss-Suard, Catherine, Kronenberg, Andreas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9219927/ https://www.ncbi.nlm.nih.gov/pubmed/35740198 http://dx.doi.org/10.3390/antibiotics11060792 |
Ejemplares similares
-
Antimicrobial resistance and antibiotic consumption in intensive care units, Switzerland, 2009 to 2018
por: Barnsteiner, Stefanie, et al.
Publicado: (2021) -
Intra-hospital differences in antibiotic use correlate with antimicrobial resistance rate in Escherichia coli and Klebsiella pneumoniae: a retrospective observational study
por: Cusini, Alexia, et al.
Publicado: (2018) -
Assessing the conversion of electronic medical record data into antibiotic stewardship indicators
por: Renggli, L, et al.
Publicado: (2023) -
Increasing proportion of vancomycin-resistance among enterococcal bacteraemias in Switzerland: a 6-year nation-wide surveillance, 2013 to 2018
por: Piezzi, Vanja, et al.
Publicado: (2020) -
Emergence of vancomycin-resistant enterococci in Switzerland: a nation-wide survey
por: Buetti, Niccolò, et al.
Publicado: (2019)